Variant report

Variant	nsv979109
Chromosome Location	chr2:114429638-114495192
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:855)
CpG islands
(count:183)
Chromatin interactive
region (count:37)
LncRNA
region (count:14)
Mature miRNA
region (count: 2)
miRNA target
sites (count:3)

(count:855 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:114464702-114465021	HepG2	liver:	n/a	n/a
2	ARID3A	chr2:114469664-114469667	HepG2	liver:	n/a	n/a
3	ARID3A	chr2:114457692-114458213	K562	blood:	n/a	n/a
4	ARID3A	chr2:114457824-114457937	HepG2	liver:	n/a	n/a
5	ATF1	chr2:114437071-114437425	K562	blood:	n/a	n/a
6	ATF2	chr2:114457703-114458119	GM12878	blood:	n/a	n/a
7	ATF2	chr2:114450992-114451895	GM12878	blood:	n/a	n/a
8	ATF2	chr2:114450181-114450739	GM12878	blood:	n/a	n/a
9	ATF2	chr2:114450125-114450742	GM12878	blood:	n/a	n/a
10	ATF2	chr2:114457610-114458053	GM12878	blood:	n/a	n/a
11	ATF2	chr2:114451050-114451495	GM12878	blood:	n/a	n/a
12	ATF2	chr2:114456570-114457191	GM12878	blood:	n/a	n/a
13	BATF	chr2:114450302-114450614	GM12878	blood:	n/a	n/a
14	BATF	chr2:114451104-114451470	GM12878	blood:	n/a	n/a
15	BATF	chr2:114450245-114450607	GM12878	blood:	n/a	n/a
16	BCL11A	chr2:114450249-114450705	GM12878	blood:	n/a	chr2:114450467-114450476
17	BCL11A	chr2:114451170-114451502	GM12878	blood:	n/a	n/a
18	BCL11A	chr2:114451174-114451583	GM12878	blood:	n/a	n/a
19	BCL11A	chr2:114450307-114450523	GM12878	blood:	n/a	chr2:114450467-114450476
20	BCL3	chr2:114451106-114451503	GM12878	blood:	n/a	n/a
21	BCLAF1	chr2:114451062-114451648	GM12878	blood:	n/a	n/a
22	BCLAF1	chr2:114457710-114458179	GM12878	blood:	n/a	n/a
23	BCLAF1	chr2:114450139-114450709	GM12878	blood:	n/a	chr2:114450467-114450476
24	BCLAF1	chr2:114450204-114450653	GM12878	blood:	n/a	chr2:114450467-114450476
25	BCLAF1	chr2:114451057-114451505	GM12878	blood:	n/a	n/a
26	BHLHE40	chr2:114457890-114458374	K562	blood:	n/a	n/a
27	BHLHE40	chr2:114451064-114451611	GM12878	blood:	n/a	n/a
28	CBX3	chr2:114457750-114458241	K562	blood:	n/a	n/a
29	CEBPB	chr2:114479224-114479386	HepG2	liver:	n/a	n/a
30	CEBPB	chr2:114464737-114465089	K562	blood:	n/a	chr2:114464905-114464916
31	CEBPB	chr2:114451144-114451505	GM12878	blood:	n/a	n/a
32	CEBPB	chr2:114464687-114465094	IMR90	lung:	n/a	chr2:114464905-114464916
33	CEBPB	chr2:114464705-114465162	MCF-7	breast:	n/a	chr2:114464905-114464916
34	CEBPB	chr2:114491117-114491491	MCF-7	breast:	n/a	chr2:114491265-114491276
35	CEBPB	chr2:114473898-114474244	K562	blood:	n/a	chr2:114474047-114474058
36	CEBPB	chr2:114491113-114491422	HepG2	liver:	n/a	chr2:114491265-114491276
37	CEBPB	chr2:114464721-114465051	A549	lung:	n/a	chr2:114464905-114464916
38	CEBPB	chr2:114473942-114474194	HepG2	liver:	n/a	chr2:114474047-114474058
39	CEBPB	chr2:114491246-114491384	A549	lung:	n/a	chr2:114491265-114491276
40	CEBPB	chr2:114464582-114465165	MCF-7	breast:	n/a	chr2:114464905-114464916
41	CEBPB	chr2:114464760-114465040	H1-hESC	embryonic stem cell:	n/a	chr2:114464905-114464916
42	CEBPB	chr2:114464723-114465061	HepG2	liver:	n/a	chr2:114464905-114464916
43	CEBPB	chr2:114473954-114474140	A549	lung:	n/a	chr2:114474047-114474058
44	CEBPB	chr2:114491124-114491448	IMR90	lung:	n/a	chr2:114491265-114491276
45	CEBPB	chr2:114459301-114459451	K562	blood:	n/a	chr2:114459371-114459382
46	CEBPB	chr2:114464751-114465030	K562	blood:	n/a	chr2:114464905-114464916
47	CEBPB	chr2:114445176-114445376	K562	blood:	n/a	n/a
48	CEBPB	chr2:114476569-114476786	IMR90	lung:	n/a	n/a
49	CEBPB	chr2:114469389-114469899	ECC-1	luminal epithelium:	n/a	chr2:114469520-114469537
50	CEBPB	chr2:114491045-114491452	MCF-7	breast:	n/a	chr2:114491265-114491276

(count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:114430284-114430334	NHDF-neo	bronchial:	n/a
2	chr2:114430284-114430334	SK-N-SH_RA	brain:	n/a
3	chr2:114430284-114430334	GM19239	blood:	n/a
4	chr2:114474155-114474205	HUVEC	blood vessel:	n/a
5	chr2:114474155-114474205	LNCaP	prostate:	n/a
6	chr2:114463932-114463982	AG10803	skin:	n/a
7	chr2:114463932-114463982	U87	brain:	n/a
8	chr2:114463932-114463982	HCT-116	colon:	n/a
9	chr2:114474155-114474205	CMK	blood:	n/a
10	chr2:114463932-114463982	MCF10A-Er-Src	breast:	n/a
11	chr2:114430284-114430334	AG09309	skin:	n/a
12	chr2:114430284-114430334	T-47D	breast:	n/a
13	chr2:114430284-114430334	BE2_C	brain:	n/a
14	chr2:114463932-114463982	T-47D	breast:	n/a
15	chr2:114463932-114463982	NH-A	brain:	n/a
16	chr2:114463932-114463982	HAEpiC	amniotic membrane:	n/a
17	chr2:114474155-114474205	Hela-S3	cervix:	n/a
18	chr2:114430284-114430334	HepG2	liver:	n/a
19	chr2:114430284-114430334	SK-N-SH	brain:	n/a
20	chr2:114463932-114463982	GM12891	blood:	n/a
21	chr2:114430284-114430334	NB4	blood:	n/a
22	chr2:114474155-114474205	GM12878	blood:	n/a
23	chr2:114474155-114474205	HL-60	blood:	n/a
24	chr2:114463932-114463982	AG04450	lung:	fetal
25	chr2:114430284-114430334	SK-N-MC	brain:	n/a
26	chr2:114474155-114474205	HepG2	liver:	n/a
27	chr2:114463932-114463982	SKMC	muscle:	n/a
28	chr2:114430284-114430334	U87	brain:	n/a
29	chr2:114474155-114474205	HEK293	kidney:	embryo
30	chr2:114474155-114474205	AoSMC	blood vessel:	n/a
31	chr2:114474155-114474205	NT2-D1	testis:	n/a
32	chr2:114463932-114463982	HCPEpiC	choroid plexus:	n/a
33	chr2:114430284-114430334	LNCaP	prostate:	n/a
34	chr2:114474155-114474205	PrEC	prostate:	n/a
35	chr2:114430284-114430334	Caco-2	colon:	n/a
36	chr2:114474155-114474205	HRE	kidney:	n/a
37	chr2:114463932-114463982	MCF-7	breast:	n/a
38	chr2:114463932-114463982	HNPCEpiC	eye:	n/a
39	chr2:114474155-114474205	ovcar-3	ovarian:	n/a
40	chr2:114430284-114430334	PANC-1	pancreas:	n/a
41	chr2:114474155-114474205	GM19239	blood:	n/a
42	chr2:114474155-114474205	HRCEpiC	kidney:	n/a
43	chr2:114430284-114430334	AG09319	gingival:	n/a
44	chr2:114474155-114474205	AG09309	skin:	n/a
45	chr2:114474155-114474205	RPTEC	kidney:	n/a
46	chr2:114430284-114430334	MCF10A-Er-Src	breast:	n/a
47	chr2:114474155-114474205	GM12892	blood:	n/a
48	chr2:114463932-114463982	PrEC	prostate:	n/a
49	chr2:114430284-114430334	BJ	skin:	n/a
50	chr2:114430284-114430334	HEEpiC	esophagus:	n/a

(count:37 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:114470204..114472162-chr2:114473968..114476714,2	K562	blood:
2	chr2:114467029..114469645-chr2:114471402..114474213,2	K562	blood:
3	chr2:114458048..114459604-chr2:114646095..114648927,2	MCF-7	breast:
4	chr2:114470204..114472162-chr2:114473968..114476714,2	K562	blood:
5	chr2:114361344..114362249-chr2:114457515..114458330,2	MCF-7	breast:
6	chr2:114492884..114495202-chr2:114498895..114501885,3	K562	blood:
7	chr2:114480781..114482978-chr2:114512798..114514341,2	K562	blood:
8	chr2:114476035..114479420-chr2:114481411..114484659,3	K562	blood:
9	chr2:114476035..114479420-chr2:114481411..114484659,3	K562	blood:
10	chr2:114482159..114484951-chr2:114491076..114492999,2	MCF-7	breast:
11	chr2:114473851..114476041-chr2:114476528..114479274,2	K562	blood:
12	chr2:114485598..114489125-chr2:114489448..114492903,4	MCF-7	breast:
13	chr2:114477814..114479515-chr2:114484887..114487513,2	K562	blood:
14	chr2:114476831..114479473-chr2:114488755..114491285,2	K562	blood:
15	chr2:114437381..114438920-chr2:114440621..114443610,2	K562	blood:
16	chr2:114488891..114491412-chr2:114512139..114514622,2	K562	blood:
17	chr2:114359257..114359811-chr2:114457510..114458087,2	MCF-7	breast:
18	chr2:114450920..114453589-chr2:114487817..114489810,2	K562	blood:
19	chr2:114482332..114485532-chr2:114485677..114488517,3	K562	blood:
20	chr2:114495189..114499777-chr2:114499993..114505139,6	K562	blood:
21	chr2:114437420..114439660-chr2:114441343..114445054,3	K562	blood:
22	chr2:114480320..114482087-chr2:114485684..114488123,2	K562	blood:
23	chr2:114482332..114485532-chr2:114485677..114488517,3	K562	blood:
24	chr2:114490228..114492106-chr2:114494949..114498699,3	K562	blood:
25	chr2:114490228..114492106-chr2:114494949..114498699,3	K562	blood:
26	chr2:114477814..114479515-chr2:114484887..114487513,2	K562	blood:
27	chr2:114480320..114482087-chr2:114485684..114488123,2	K562	blood:
28	chr2:114489220..114494215-chr2:114513189..114517576,5	K562	blood:
29	chr2:114491572..114494215-chr2:114513189..114515373,3	K562	blood:
30	chr2:114446767..114449661-chr2:114451262..114453281,2	K562	blood:
31	chr2:114284812..114285348-chr2:114457736..114458446,2	MCF-7	breast:
32	chr2:114446767..114449661-chr2:114451262..114453281,2	K562	blood:
33	chr2:114490228..114492803-chr2:114497199..114499336,2	K562	blood:
34	chr2:114489926..114491643-chr2:114503029..114505332,2	K562	blood:
35	chr2:114450920..114453589-chr2:114487817..114489810,2	K562	blood:
36	chr2:114361263..114362251-chr2:114457536..114458288,3	MCF-7	breast:
37	chr2:114467029..114469645-chr2:114471402..114474213,2	K562	blood:

(count:14 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RABL2A-5	chr2:114481066-114481349	NONHSAT073828
2	lnc-RABL2A-5	chr2:114453616-114454175	NONHSAT073828
3	lnc-AC016745.1-2	chr2:114466280-114467816	XLOC_002282
4	lnc-RABL2A-5	chr2:114456711-114456810	l_1932_chr2:114450946-114476823_testes
5	lnc-RABL2A-5	chr2:114456711-114457305	NONHSAT073829
6	lnc-AC016745.1-2	chr2:114464370-114465202	XLOC_002282
7	lnc-RABL2A-5	chr2:114481066-114481354	l_1932_chr2:114450946-114476823_testes
8	lnc-RABL2A-5	chr2:114453956-114454175	NONHSAT073829
9	lnc-RABL2A-1	chr2:114430157-114430315	XLOC_001633
10	lnc-RABL2A-5	chr2:114475938-114476823	l_1932_chr2:114450946-114476823_testes
11	lnc-RABL2A-5	chr2:114450947-114454451	l_1932_chr2:114450946-114476823_testes
12	lnc-RABL2A-3	chr2:114432688-114433000	expReg_chr2_8797_+
13	lnc-RABL2A-5	chr2:114457238-114457575	l_1932_chr2:114450946-114476823_testes
14	lnc-RABL2A-1	chr2:114430446-114430768	XLOC_001633

miRNA name	Chromosome Location	mirBase accession
hsa-miR-4782-3p	chr2:114478875-114478896	MIMAT0019945
hsa-miR-4782-5p	chr2:114478915-114478936	MIMAT0019944

(count:3 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location
1	SLC35F5	hsa-miR-142-3p	chr2:114472197-114472219
2	SLC35F5	hsa-miR-142-3p	chr2:114472585-114472607
3	SLC35F5	hsa-miR-142-3p	chr2:114474760-114474753

Variant related genes	Relation type
ENSG00000227359	TF binding region
RNU6-744P	TF binding region
MIR4782	TF binding region
ENSG00000175509	TF binding region
SLC35F5	TF binding region
ENSG00000227359	CpG island
RNU6-744P	CpG island
MIR4782	CpG island
ENSG00000175509	CpG island
SLC35F5	CpG island
ENSG00000115091	chromatin interactions
ENSG00000115084	chromatin interactions
ENSG00000265429	chromatin interactions
ENSG00000202427	chromatin interactions
ENSG00000270019	chromatin interactions
TDG	miRNA target sites
OSBP	miRNA target sites
SNX4	miRNA target sites

Extended variants
information (count: 2335 )
Associated
traits (count: 52 )

Variant overlapped rSNPs/rCNVs (count:2335 , 50 per page) page: 1 2 3 4 5 6 7 ... 47

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs558581947	chr2:114429647-114429648	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs572145483	chr2:114429648-114429649	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs143585784	chr2:114429694-114429695	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs561164357	chr2:114429703-114429704	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs529820010	chr2:114429723-114429724	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs537535866	chr2:114429801-114429802	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs113590824	chr2:114429807-114429808	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs563200492	chr2:114429879-114429880	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs57692222	chr2:114429926-114429927	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs551403805	chr2:114429964-114429965	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs72944621	chr2:114430014-114430015	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs201106141	chr2:114430030-114430031	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs12620183	chr2:114430089-114430090	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
14	rs12711778	chr2:114430166-114430167	Bivalent Enhancer Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
15	rs567864817	chr2:114430194-114430195	Bivalent Enhancer Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
16	rs559030462	chr2:114430212-114430213	Bivalent Enhancer Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
17	rs536405797	chr2:114430224-114430225	Bivalent Enhancer Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
18	rs556899998	chr2:114430226-114430227	Bivalent Enhancer Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
19	rs112895378	chr2:114430285-114430286	Bivalent Enhancer Enhancers Weak transcription	CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
20	rs570410386	chr2:114430322-114430323	Bivalent Enhancer Enhancers Weak transcription	CpG island	1 gene(s)	Overlapped CNVs	n/a
21	rs139499700	chr2:114430331-114430332	Bivalent Enhancer Enhancers Weak transcription	CpG island	1 gene(s)	Overlapped CNVs	n/a
22	rs558620028	chr2:114430350-114430351	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs182095095	chr2:114430351-114430352	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs541139781	chr2:114430397-114430398	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs59544264	chr2:114430402-114430403	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs199980191	chr2:114430403-114430404	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs144746054	chr2:114430406-114430407	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs528149338	chr2:114430461-114430462	Bivalent Enhancer Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
29	rs554330904	chr2:114430496-114430497	Bivalent Enhancer Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
30	rs574583493	chr2:114430514-114430515	Bivalent Enhancer Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
31	rs149251947	chr2:114430553-114430554	Bivalent Enhancer Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
32	rs144432523	chr2:114430560-114430561	Bivalent Enhancer Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
33	rs532309656	chr2:114430590-114430591	Bivalent Enhancer Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
34	rs545674124	chr2:114430606-114430607	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
35	rs565305571	chr2:114430763-114430764	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
36	rs527651566	chr2:114430904-114430905	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs551066187	chr2:114430920-114430921	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs547880217	chr2:114430974-114430975	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs567606711	chr2:114430975-114430976	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs114793763	chr2:114430988-114430989	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs550436442	chr2:114431043-114431044	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs570247620	chr2:114431085-114431086	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs539368933	chr2:114431087-114431088	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs139779951	chr2:114431102-114431103	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs11899799	chr2:114431220-114431221	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs534278795	chr2:114431235-114431236	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs75265906	chr2:114431262-114431263	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs113134726	chr2:114431304-114431305	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs574492398	chr2:114431324-114431325	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs144513904	chr2:114431361-114431362	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:52)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Mowat-Wilson syndrome	21572526	CNVD
Disorders of sex development	21048976	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
lymphocytic leukemia	21291569	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Colorectal cancer	16272173	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
myoclonus epilepsy	18472482	CNVD
Benign familial neonatal-infantile seizures	18472482	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Myelofibrosis	22110671	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Neuroticism	17667963	CNVD

Chromatin state (count:1199 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:114424800-114433400	Weak transcription	Sigmoid Colon	Sigmoid Colon
2	chr2:114429400-114430600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
3	chr2:114429400-114430600	Enhancers	H9 Cell Line	embryonic stem cell
4	chr2:114429400-114430600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr2:114429400-114430800	Enhancers	iPS-18 Cell Line	embryonic stem cell
6	chr2:114429400-114434800	Weak transcription	Rectal Mucosa Donor 31	rectum
7	chr2:114429600-114430000	Enhancers	HUES64 Cell Line	embryonic stem cell
8	chr2:114429600-114430200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
9	chr2:114429600-114430400	Enhancers	iPS-20b Cell Line	embryonic stem cell
10	chr2:114429600-114430600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
11	chr2:114429600-114430600	Enhancers	Primary hematopoietic stem cells short term culture	blood
12	chr2:114429600-114430600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
13	chr2:114429600-114431000	Enhancers	HUES48 Cell Line	embryonic stem cell
14	chr2:114429800-114430200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
15	chr2:114429800-114430600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
16	chr2:114429800-114433000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
17	chr2:114430000-114430400	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
18	chr2:114430000-114431200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
19	chr2:114430200-114430600	Enhancers	HUES6 Cell Line	embryonic stem cell
20	chr2:114432000-114432200	Enhancers	K562	blood
21	chr2:114432200-114433200	Weak transcription	K562	blood
22	chr2:114432800-114433000	Enhancers	Left Ventricle	heart
23	chr2:114432800-114433000	Enhancers	Right Atrium	heart
24	chr2:114432800-114434600	Enhancers	Spleen	Spleen
25	chr2:114433000-114433600	Weak transcription	Left Ventricle	heart
26	chr2:114433000-114434000	Weak transcription	Right Atrium	heart
27	chr2:114433200-114433600	Bivalent Enhancer	HepG2	liver
28	chr2:114433200-114434000	Enhancers	K562	blood
29	chr2:114433200-114434600	Enhancers	Adipose Nuclei	Adipose
30	chr2:114433400-114434200	Enhancers	Fetal Muscle Leg	muscle
31	chr2:114433600-114433800	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
32	chr2:114433600-114433800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
33	chr2:114433600-114433800	Flanking Bivalent TSS/Enh	HepG2	liver
34	chr2:114433600-114434600	Enhancers	Left Ventricle	heart
35	chr2:114433800-114434000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
36	chr2:114433800-114434000	Bivalent Enhancer	HepG2	liver
37	chr2:114434000-114435200	Weak transcription	K562	blood
38	chr2:114434000-114435600	Enhancers	Fetal Heart	heart
39	chr2:114434000-114435800	Enhancers	Right Atrium	heart
40	chr2:114434200-114435800	Enhancers	Right Ventricle	heart
41	chr2:114434800-114435000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
42	chr2:114435200-114435800	Enhancers	K562	blood
43	chr2:114435200-114436400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
44	chr2:114435800-114437000	Weak transcription	K562	blood
45	chr2:114436400-114437800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
46	chr2:114436800-114437200	Enhancers	Primary T helper naive cells from peripheral blood	blood
47	chr2:114437000-114437600	Enhancers	K562	blood
48	chr2:114437000-114438000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
49	chr2:114437000-114438000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
50	chr2:114437600-114438400	Enhancers	Fetal Lung	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links